PLERIXAFOR
- Product NDC
- 70710-1208
- 11-digit product format
- 707101208
- Labeler code
- 70710
- Product ID
- 70710-1208_6eded16b-f43d-4984-bd7c-33ca6d5e3195
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- plerixafor
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Application
- ANDA208980
- Marketing category
- ANDA
- Marketing start
- 2023-07-28
- Substance
- PLERIXAFOR
- Active strength
- 24 mg/1.2mL
- Pharmacologic classes
- Hematopoietic Stem Cell Mobilizer [EPC], Increased Hematopoietic Stem Cell Mobilization [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| S915P5499N | PLERIXAFOR | 110078-46-1 | PLERIXAFOR |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 70710-1208-1 | 70710120801 | 1 VIAL, SINGLE-USE in 1 CARTON (70710-1208-1) / 1.2 mL in 1 VIAL, SINGLE-USE | 2023-07-28 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| PLERIXAFOR | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 2024-12-06 | HUMAN PRESCRIPTION DRUG LABEL | 3 |